hsa04151 | PI3K-Akt signaling pathway | 24 | 45.28301887 | 1.46E−18 | GSK3B, CDKN1A, NOS3, ITGB3, INSR, EGFR, PIK3CG, RELA, VEGFA, CASP9, IL4, IL6, RXRA, CCND1, CDK4, MYC, ERBB2, CDK2, MDM2, BCL2, MAPK1, MET, TP53, BCL2L1 | 10.61538462 | 4.28E−17 |
hsa05417 | Lipid and atherosclerosis | 20 | 37.73584906 | 1.03E−17 | GSK3B, JUN, NOS3, MMP1, STAT3, FOS, TNF, MMP9, RELA, ICAM1, CASP9, IL6, RXRA, CD40LG, CASP3, BCL2, MAPK1, PPARG, TP53, BCL2L1 | 14.56529517 | 2.26E−16 |
hsa01522 | Endocrine resistance | 15 | 28.30188679 | 4.50E−16 | RB1, CDKN1A, JUN, MMP2, FOS, ESR1, MMP9, EGFR, CCND1, CDK4, ERBB2, MDM2, BCL2, MAPK1, TP53 | 23.96585557 | 5.65E−15 |
hsa04933 | AGE-RAGE signaling pathway in diabetic complications | 15 | 28.30188679 | 6.03E−16 | JUN, EDN1, NOS3, MMP2, STAT3, TNF, RELA, ICAM1, VEGFA, IL6, CCND1, CDK4, CASP3, BCL2, MAPK1 | 23.48653846 | 5.75E−15 |
hsa04066 | HIF-1 signaling pathway | 15 | 28.30188679 | 2.21E−15 | CDKN1A, EDN1, NOS2, NOS3, INSR, STAT3, EGFR, RELA, VEGFA, IL6, IFNG, ERBB2, BCL2, MAPK1, HMOX1 | 21.54728299 | 1.62E−14 |
hsa05418 | Fluid shear stress and atherosclerosis | 15 | 28.30188679 | 6.95E−14 | JUN, EDN1, NOS3, ITGB3, MMP2, FOS, TNF, MMP9, RELA, ICAM1, VEGFA, IFNG, BCL2, HMOX1, TP53 | 16.89679026 | 3.60E−13 |
hsa04657 | IL-17 signaling pathway | 13 | 24.52830189 | 2.99E−13 | GSK3B, JUN, MMP1, FOS, PTGS2, TNF, MMP9, RELA, IL4, IL6, IFNG, CASP3, MAPK1 | 21.65425532 | 1.46E−12 |
hsa04010 | MAPK signaling pathway | 13 | 24.52830189 | 1.76E−07 | JUN, INSR, FOS, TNF, EGFR, RELA, VEGFA, MYC, CASP3, ERBB2, MAPK1, MET, TP53 | 6.923469388 | 3.11E−07 |
hsa04926 | Relaxin signaling pathway | 12 | 22.64150943 | 2.86E−10 | EDN1, JUN, NOS2, MMP1, NOS3, MMP2, MAPK1, FOS, MMP9, RELA, EGFR, VEGFA | 14.56529517 | 8.98E−10 |
hsa04218 | Cellular senescence | 12 | 22.64150943 | 2.21E−09 | RB1, IL6, CDKN1A, CCNB1, CCND1, CDK4, MYC, CDK2, MDM2, MAPK1, TP53, RELA | 12.0443787 | 5.25E−09 |
hsa04115 | p53 signaling pathway | 11 | 20.75471698 | 1.69E−11 | CASP9, CDKN1A, CCNB1, CCND1, CDK4, CASP3, CDK2, MDM2, BCL2, TP53, BCL2L1 | 23.59378293 | 6.48E−11 |
hsa04660 | T cell receptor signaling pathway | 11 | 20.75471698 | 6.16E−10 | IL10, IL4, GSK3B, JUN, CD40LG, IFNG, CDK4, MAPK1, FOS, TNF, RELA | 16.56102071 | 1.81E−09 |
hsa04668 | TNF signaling pathway | 11 | 20.75471698 | 1.29E−09 | IL6, EDN1, JUN, CASP3, MAPK1, FOS, PTGS2, TNF, MMP9, RELA, ICAM1 | 15.37809066 | 3.24E−09 |
hsa04110 | Cell cycle | 11 | 20.75471698 | 4.11E−09 | RB1, GSK3B, CDKN1A, CCNB1, PCNA, CCND1, CDK4, MYC, CDK2, MDM2, TP53 | 13.66941392 | 9.51E−09 |
hsa04068 | FoxO signaling pathway | 11 | 20.75471698 | 6.01E−09 | IL10, IL6, CDKN1A, CCNB1, CCND1, INSR, STAT3, CDK2, MDM2, MAPK1, EGFR | 13.14768056 | 1.32E−08 |
hsa04630 | JAK-STAT Signaling pathway | 11 | 20.75471698 | 4.66E−08 | IL10, IL4, IL6, CDKN1A, IFNG, CCND1, MYC, STAT3, BCL2, EGFR, BCL2L1 | 10.63176638 | 9.03E−08 |
hsa01521 | EGFR tyrosine kinase inhibitor resistance | 10 | 18.86792453 | 1.05E−09 | GSK3B, IL6, ERBB2, STAT3, BCL2, MAPK1, MET, EGFR, BCL2L1, VEGFA | 19.81986368 | 2.71E−09 |
hsa04919 | Thyroid hormone signaling pathway | 10 | 18.86792453 | 4.72E−08 | CASP9, GSK3B, RXRA, CCND1, MYC, ITGB3, MDM2, MAPK1, ESR1, TP53 | 12.94024158 | 9.03E−08 |
hsa04210 | Apoptosis | 10 | 18.86792453 | 1.30E−07 | CASP9, JUN, CASP3, BCL2, MAPK1, FOS, TNF, TP53, RELA, BCL2L1 | 11.51300905 | 2.34E−07 |
hsa04510 | Focal adhesion | 10 | 18.86792453 | 3.53E−06 | GSK3B, JUN, CCND1, ITGB3, ERBB2, BCL2, MAPK1, MET, EGFR, VEGFA | 7.78989667 | 5.09E−06 |